Cefiderocol
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Bacterial Infections
Conditions
Bacterial Infections
Trial Timeline
— → —
NCT ID
NCT03780140About Cefiderocol
Cefiderocol is a pre-clinical stage product being developed by Shionogi for Bacterial Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT03780140. Target conditions include Bacterial Infections.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (7)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03780140 | Pre-clinical | Completed |
| NCT07465432 | Approved | Recruiting |
| NCT05789199 | Pre-clinical | Completed |
| NCT05373615 | Phase 1 | Completed |
| NCT05314764 | Approved | Completed |
| NCT04995835 | Phase 1 | Completed |
| NCT03869437 | Phase 2 | Completed |
Competing Products
20 competing products in Bacterial Infections